国际眼科杂志Issue(12)：2421-2423,3.DOI:10.3980/j.issn.1672-5123.2013.12.16
抗 VEGF 药物治疗早产儿视网膜病变的研究进展
Researches advance on anti -VEGF medication for retinopathy of prematurity
赵欢欢 1黄学林 1谢素贞 1赵朝辉2
作者信息
- 1. 511400 中国广东省广州市，广东省妇幼保健院眼科
- 2. 510150 中国广东省广州市，广州医科大学附属第三医院手术室
- 折叠
摘要
Abstract
Retinopathy ofprematurity ( ROP) is one of the major cause of childhood blindness worldwide.Previously, the treatment for ROP for the patients at the threshold period and before high-risk period is mainly the retinal laser and cryotherapy. However, cryotherapy and laser therapy are destructive, which can inevitably result in permanent peripheral field loss and more complications. Some patients'states of illness can't be controlled after surgery and end with total loss of vision.Hence, a new treatment method should be explored.Recently, many clinical data showed that anti -vascular endothelial growth factor therapy may be effective in treating retinopathy of prematurity. This article reviewed the recent literature on the research and progress of anti-vascular endothelial growth factor ( anti-VEGF) drugs in the treatment of retinopathy of prematurity.关键词
早产儿视网膜病变/血管内皮生长因子/视网膜新生血管Key words
retinopathy of prematurity/vascular endothelial growth factor/retinal neovascularization引用本文复制引用
赵欢欢,黄学林,谢素贞,赵朝辉..抗 VEGF 药物治疗早产儿视网膜病变的研究进展[J].国际眼科杂志,2013,(12):2421-2423,3.
